期刊名称：FUTURE MEDICINAL CHEMISTRY
 期刊简介(About the journal)
编辑部信息(Editorial Board)
About the journal
Medicinal chemistry has evolved rapidly into a highly interdisciplinary field, enriched by the collaborative efforts of experts from a wide spectrum of specialist areas, from chemoinformaticians and physical chemists to molecular biologists and pharmacologists. Future Medicinal Chemistry provides a monthly point of access to commentary and debate for this ever-expanding and diversifying community. The journal showcases milestones in pharmaceutical R&D and features expert analysis of emerging research-from the identification of targets, through to the discovery, design, synthesis and evaluation of bioactive agents.
There has never been more pressure to produce potent and safe compounds faster and more efficiently. Future Medicinal Chemistry offers a forum for the rapid publication of original research and critical reviews of the latest milestones in the field. Strong emphasis is placed on ensuring that the journal stimulates awareness of issues that are anticipated to play an increasingly central role in influencing the future direction of pharmaceutical chemistry. Where relevant, contributions are also actively encouraged on areas as diverse as biotechnology, enzymology, green chemistry, genomics, immunology, materials science, neglected diseases and orphan drugs, pharmacogenomics, proteomics and toxicology.
Principal themes include:
Drug discovery technologies
Design and synthesis of novel lead compounds
Computational approaches to synthesis and modeling
Biophysical techniques for structural characterization
Overviews of novel therapeutic strategies and emerging targets
Drug targeting and delivery
ADME/Tox investigations
Commentary on science policy, economic and IP issues
In addition to its core content of Reviews, Patent Reviews, Perspectives and Original Research, the journal also features enlightened commentary and opinion on topical areas of debate relevant to academia and industry, as well as conference reports, interviews and more.
By remaining highly responsive to emerging themes, and providing in-depth analysis of agents of medicinal interest and therapeutic approaches, the journal will act as a valuable reference, not only for medicinal chemists, but for all those interested in the advancement of pharmaceutical science.
Indexing
Chemical Abstracts
EMBASE/Excerpta Medica
Scopus
Science Citation Index Expanded (also known as SciSearch®)
Journal Citation Reports/Science Edition
Chemistry Citation Index®
BIOSIS Previews
BIOSIS Reviews Reports and Meetings
Editorial Board
Senior Editors
Ojima I, State University of New York at Stony Brook, USA
Thurston DE, University of London, UK
Associate Editors
Albericio F,University of Barcelona, Spain
Barlocco D,University of Milan, Italy
Fischer PM, University of Nottingham, UK
Golding B, University of Newcastle, UK
Honek JF,University of Waterloo, Canada
Johnston G,University of Sydney, Australia
Jones K, Cancer Research UK, UK
Laughton C, University of Nottingham, UK
Mátyus P, Semmelweis University, Hungary
Ramachandran PV, Purdue University, USA
Reynolds CA, University of Essex, UK
Ruan K, University of Houston, USA
Woodard RW, University of Michigan, USA
Advisory Board
Amin S, Pennsylvania State University, USA
Augustyns K, University of Antwerp, Belgium
Badet B, Inst. de Chimie des Substances Naturelles, France
Baell J, Walter & Eliza Hall Institute of Medical Research, Australia
Baldwin JJ, Cleo Pharmaceuticals, USA
Ben R, University of Ottowa, Canada
Blagg BSJ, University of Kansas, USA
Calabrese A, Signal Pharmaceuticals, USA
Castro L, EISAI London Research Laboratories Ltd, UK
Chauhan PMS, Central Drug Research Institute, Lucknow, India
Chmielewski J, Purdue University, USA
Costantino L, University of Modena, Italy
Cottens S, Novartis Inst. for BioMedical Research, Switzerland
d’Alarcao M, San José State University, USA
de Souza N, Inst. of Chemical Technology, India
Denonne F, UCB Pharma, Beligum
Eaton M,
Ecker G, University of Vienna, Austria
Ferguson DM, University of Minnesota, USA
Ghosh AK, Purdue University, USA
Gilbert I, University of Dundee, UK
Gold B, University of Pittsburgh, USA
Golenser J, Hebrew University, Israel
Graczyk PP, EISAI London Research Laboratories, UK
Hale KJ, Queen’s University, Belfast, N. Ireland
Hall J, ETH Zurich, Switzerland
Herdewijn P, Katholieke Univ. Leuven, Belgium
Hrycyna CA, Purdue University, USA
Huleatt P, Institute of Chemical and Engineering Sciences, Singapore
Jacobson KA, NIH, USA
Jolliffe K and Kalinowski D, University of Sydney, Australia
Kellam B, University of Nottingham, UK
Kimball D, Pharmacopeia Inc, USA
Kozmin S, University of Chicago, USA
Laggner C, University of California, San Francisco, USA
Langer T, Prestwick Chemical Inc, France
Ling CC, University of Calgary, Canada
Lowe TL, Pennsylvania State University, USA
Matta CF, Mount St. Vincent University, Canada
McCurdy CR, University of Mississippi, USA
Meldal M, Carlsberg Laboratory, Denmark
Merz KM, University of Florida, USA
Miners J, Flinders University, Australia
Monteiro MA, University of Guelph, Canada
Nicklaus MC, National Cancer Inst. at Frederick, USA
Potter B, University of Bath, UK
Prisinzano TE, University of Kansas, USA
Richardson D, University of Sydney, Australia
Rigby AC, University of Harvard, USA
Schmidt M, Indiana University, USA
Schneider G, ETH Zurich, Switzerland
Schubert-Zsilavecz M, Johann Wolfgang Goethe-University, Germany
Searcey M, University of East Anglia, UK
Sheridan RP, Merck Research Laboratories, USA
Sippl W, Martin-Luther-Universität Halle-Wittenberg, Germany
Spencer J, University of Greenwich, UK
Talaga P, UCB Pharma, Belgium
Trotta F, Italian Medicines Agency, Italy
Wiese M, University of Bonn, Germany
Whitty A, Boston University, USA
Xing C, University of Minnesota, USA
|
